- Home
- IR vs BNTX Comparison
IR vs BNTX Comparison
Compare IR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IR
- BNTX
- Stock Information
- Founded
- IR 1859
- BNTX 2008
- Country
- IR United States
- BNTX Germany
- Employees
- IR N/A
- BNTX N/A
- Industry
- IR Industrial Machinery/Components
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IR Industrials
- BNTX Health Care
- Exchange
- IR Nasdaq
- BNTX Nasdaq
- Market Cap
- IR 31.1B
- BNTX 26.4B
- IPO Year
- IR N/A
- BNTX 2019
- Fundamental
- Price
- IR $81.00
- BNTX $104.31
- Analyst Decision
- IR Buy
- BNTX Strong Buy
- Analyst Count
- IR 10
- BNTX 18
- Target Price
- IR $98.70
- BNTX $139.49
- AVG Volume (30 Days)
- IR 2.6M
- BNTX 879.0K
- Earning Date
- IR 10-30-2025
- BNTX 11-03-2025
- Dividend Yield
- IR 0.10%
- BNTX N/A
- EPS Growth
- IR N/A
- BNTX N/A
- EPS
- IR 1.29
- BNTX N/A
- Revenue
- IR $7,364,300,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- IR $8.22
- BNTX N/A
- Revenue Next Year
- IR $5.35
- BNTX $15.19
- P/E Ratio
- IR $62.70
- BNTX N/A
- Revenue Growth
- IR 4.67
- BNTX 6.98
- 52 Week Low
- IR $65.61
- BNTX $81.20
- 52 Week High
- IR $106.03
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- IR 52.72
- BNTX 46.88
- Support Level
- IR $79.02
- BNTX $99.90
- Resistance Level
- IR $81.50
- BNTX $114.89
- Average True Range (ATR)
- IR 1.82
- BNTX 3.56
- MACD
- IR 0.33
- BNTX -0.13
- Stochastic Oscillator
- IR 75.23
- BNTX 33.58
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.